Verde Science Stock

Verde Science Equity

The The Equity of Verde Science (VRCI) as of Aug 1, 2026 is -794,500.00 USD.

Equity

-794,500.00USD

Last updated:

In 2026, Verde Science's equity was -794,500.00 USD, a % increase from the - USD equity in the previous year.

Access this data via the Eulerpool API

Verde Science Stock analysis

What does Verde Science do? Verde Science Inc is an American company specializing in the development of cannabis products for medical use. It was founded in 2014 by Dr. Mike Dorsey and is headquartered in Fayetteville, Arkansas. The idea for starting the company arose when Dr. Dorsey treated many patients with serious illnesses that conventional medications were not sufficient for. He recognized the potential of cannabis as an alternative and decided to start a company specializing in the development of high-quality cannabis products for medical use. Verde Science's business model is based on the production of cannabinoid-based medications for patients with various health problems. The company employs an integrated value chain that allows it to handle the entire production and processing process in-house, from planning and research to manufacturing and marketing. The company has established different divisions to expand its activities into various areas of the market. One of the main divisions is research and development, where the company constantly works on new products and technologies to better tap into the potential of cannabis as medicine. The second division is the production of cannabinoid-based medications that can be used to treat various diseases. The company manufactures various products, including oils, creams, capsules, and tinctures, with each product tailored to the specific needs of the patient. Another division is the distribution of the products. The company specializes in online sales and operates its own online shop, delivering products directly to customers. Additionally, the company collaborates with various distribution partners to distribute its products through pharmacies, specialized doctors, and health centers. Verde Science is known for its high-quality products made from natural and organically grown raw materials. The products are free from pesticides and other chemicals and undergo testing in modern laboratories to ensure optimal quality and effectiveness. Another focus of Verde Science is educating patients and medical professionals about the use of cannabinoids as medicine. The company offers training and seminars to increase awareness of the benefits of cannabis as an alternative to conventional medications. In summary, Verde Science Inc offers high-quality cannabinoid-based medications for various health problems. The company specializes in research, development, production, and distribution of high-quality cannabis products. The raw materials used in the products are organic and free from pesticides and other chemicals. Verde Science has also focused on educating and training patients and medical personnel to promote the use of cannabinoids as medicine. Verde Science is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Verde Science's Equity

Verde Science's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Verde Science's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Verde Science's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Verde Science's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Verde Science’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Verde Science stock

The Equity of Verde Science is -794,500.00 USD in 2026.

Access this data via the Eulerpool API

Balance Sheet — Verde Science

All Key Metrics — Verde Science